Last reviewed · How we verify
NCT05503992
Evaluating the Efficacy of Using a Digital Consumption Management Tool for Family Planning in Zambia
NA trial testing Intervention package in Family Planning in 2,523 participants. Completed in 8 December 2023.
1 December 2023
Quick facts
| Lead sponsor | Boston University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 2,523 |
| Start date | 5 November 2022 |
| Primary completion | 1 December 2023 |
| Estimated completion | 8 December 2023 |
| Sites | 3 locations across Zambia |
Drugs / interventions tested
- Intervention package
Conditions studied
- Family Planning — all drugs for Family Planning →
Sponsor
Boston University
Who can join
Adults 18 to 49, female only, with Family Planning. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary objective of this evaluation is to understand the effectiveness of the OpenSRP platform on unmet family planning (FP) demand in rural Zambia. The specific objectives are to: 1. assess the impact of the intervention on satisfaction and use of modern family planning methods among last-mile people of childbearing potential; and 2. understand the impact of the intervention on FP inventory management and dispensing. The investigators will employ mixed-methods for data collection for this two-arm cluster-randomized trial. This effectiveness evaluation will be paired with a concurrent implementation evaluation, making it a Type 2 Hybrid Design. For the impact evaluation data will be collected from two main sources at both baseline and endline: 1) existing stock management records (eLMIS and paper records, depending on study arm); and 2) Short phone surveys with people of childbearing potential in the community.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05503992
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Family Planning
Currently open trials in the same condition.
- NCT06923189 — Efficacy Testing of a Multi-Level Family Planning Intervention · Phase 2, PHASE3 · recruiting
- NCT04558229 — RCT Evaluating Standardized Counseling on Early Discontinuation for Irregular Bleeding in Nexplanon Users · Phase 4 · active not recruiting
Other Boston University trials
Trials by the same sponsor.
- NCT07199634 — Integrating U=U Into HIV Counseling in South Africa (INTUIT-2.0) · NA · not yet recruiting
- NCT05838378 — Cigarillo Warnings Image Sorting Study · NA · completed
- NCT06088277 — Texting to Reduce Human Immunodeficiency Virus (HIV) Risk · NA · recruiting
- NCT06455111 — Evaluation of an Artificial Intelligence-Assisted, Image-Based Dietary Assessment Tool in the Framingham Heart Study · NA · completed
- NCT06003439 — Vaping Prevention and Vaping in Youth (Vapechat) · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05503992 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Boston University
- Last refreshed: 20 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05503992.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing